Printed on 3/17/2026
For informational purposes only. This is not medical advice.
The Modified Centor Score (also called the McIsaac Score) is a clinical prediction rule used to estimate the likelihood of Group A Streptococcal (GAS) pharyngitis. The original Centor criteria (1981) included four findings: tonsillar exudates, tender anterior cervical lymph nodes, fever, and absence of cough. McIsaac (1998) added an age modifier to improve accuracy. The score guides whether to test with a Rapid Antigen Detection Test (RADT), prescribe empiric antibiotics, or neither — helping reduce unnecessary antibiotic use. For respiratory infections with pneumonia concern, assess severity with [CURB-65 Score](/tools/curb-65). For sepsis risk, monitor with [SOFA Score](/tools/sofa-score) or [APACHE II](/tools/apache-ii-score).
Formula: Score = Exudates + Nodes + Fever + No Cough + Age modifier. Range −1 to 5.
Examine the oropharynx for tonsillar exudates or swelling (white/yellow patches on tonsils or enlarged tonsils), palpate for tender anterior cervical lymph nodes (soft, painful nodes in the anterior neck triangle), and measure temperature (fever is >38°C or 100.4°F). Ask about cough — absence of cough suggests bacterial rather than viral etiology. These four clinical findings form the original Centor criteria.
Add the age-based modifier: +1 point for ages 3-14 years (peak strep incidence), 0 points for ages 15-44 years (moderate risk), or -1 point for age ≥45 years (lower strep probability). Sum all points to get the Modified Centor (McIsaac) score, which ranges from -1 to 5. The score correlates with Group A Strep probability: 0 or below = 1-2.5%, score 1 = 5-10%, score 2 = 11-17%, score 3 = 28-35%, score 4-5 = 51-53%.
Use the score to guide management per IDSA/AHA recommendations: Score ≤1 = No testing, no antibiotics (very low probability, symptom management only). Score 2-3 = Rapid Antigen Detection Test (RADT), treat if positive, confirm negative RADT with throat culture in children. Score 4-5 = Either empiric antibiotics (penicillin or amoxicillin 10 days) or RADT confirmation before treating. This approach balances appropriate strep treatment with antibiotic stewardship.
Family Medicine & Internal Medicine Physicians
Assessing adult and pediatric patients presenting with sore throat as chief complaint in office settings. Centor Score reduces unnecessary rapid strep tests and antibiotics in low-probability patients while ensuring appropriate testing and treatment in moderate-to-high probability cases. Helps meet antibiotic stewardship quality metrics and reduces healthcare costs without sacrificing clinical outcomes.
Pediatricians & Family Medicine
Children ages 5-15 have the highest incidence of Group A Strep pharyngitis (15-30% of sore throats in this age group). Centor Score with the +1 age modifier for children 3-14 appropriately increases testing threshold. For pediatric patients, negative RADT should be confirmed with throat culture due to higher pre-test probability and greater risk of complications like acute rheumatic fever in untreated strep.
Urgent Care Providers & Nurse Practitioners
Rapid triage of sore throat complaints in urgent care settings where patients expect quick evaluation and often anticipate antibiotics. Centor Score provides objective, evidence-based rationale for clinical decisions, facilitates shared decision-making ('Your score is 1, which means very low probability of strep, so testing isn't recommended'), and reduces inappropriate antibiotic prescribing pressure.
Emergency Medicine Physicians & PAs
Distinguishing simple viral pharyngitis (can be discharged with symptom management) from bacterial pharyngitis requiring antibiotics or serious infections requiring further workup. Low Centor scores allow safe discharge without testing in the busy ED. High scores with concerning features (trismus, drooling, severe dysphagia, respiratory distress) should prompt consideration of peritonsillar abscess or retropharyngeal abscess requiring imaging and ENT consultation.
Telemedicine Providers
Assessing sore throat complaints remotely where physical examination is limited. Patients can report fever (measured at home), presence/absence of cough, and visible tonsillar swelling or exudates (using phone camera or asking patient to look in mirror with flashlight). While not ideal, Centor Score can guide whether in-person evaluation with RADT is needed or if symptomatic care alone is appropriate for low-risk presentations.
Clinical Pharmacists & Stewardship Teams
Monitoring and improving antibiotic prescribing for pharyngitis at the population level. Pharmacists can audit prescribing patterns, identify providers with high rates of empiric antibiotics for low Centor scores, provide feedback, and support implementation of evidence-based testing algorithms. Centor Score is a measurable quality indicator for appropriate antibiotic use in pharyngitis.
If the patient has rhinorrhea, congestion, hoarseness, conjunctivitis, or diarrhea along with sore throat, this strongly suggests viral etiology (common cold, influenza, COVID-19). These patients should not receive Centor scoring or strep testing regardless of throat findings. Testing viral pharyngitis leads to false positives and unnecessary antibiotic exposure. Focus on symptomatic treatment.
While tonsillar exudates contribute a point to the Centor score, they occur in many viral infections including Epstein-Barr virus (mono), adenovirus, and even some cases of COVID-19. Never diagnose strep based on exudates alone. Similarly, the absence of exudates does not rule out strep — about 30-40% of GAS pharyngitis cases lack exudates. Always use the complete score, not individual components.
The Centor score specifically requires tender anterior cervical lymph nodes (along the front of the sternocleidomastoid muscle). Posterior cervical, submandibular, or generalized lymphadenopathy does not count. Tender anterior nodes are relatively specific for bacterial pharyngitis. Posterior nodes suggest viral infection or infectious mononucleosis. Palpate systematically and only count anterior nodes.
For scores of 2-3 where testing is recommended but probability is still relatively low (11-35%), engage patients in shared decision-making. Explain: 'Your score suggests about a 20-30% chance of strep. We can do a quick test to know for sure, or we can treat your symptoms and see if you improve over 2-3 days. What's your preference?' This respects patient autonomy and often reduces unnecessary testing.
If RADT confirms strep, penicillin V (phenoxymethylpenicillin) 500 mg twice or three times daily for 10 days, or amoxicillin 500 mg twice daily for 10 days, are first-line treatments. Azithromycin (5 days) is convenient but has higher resistance rates and should be reserved for penicillin allergy. Always treat for 10 days to prevent acute rheumatic fever — short courses are inadequate.
Rapid strep tests have sensitivity of 85-95%. While specificity is >95%, the 5-15% false negative rate matters more in children due to higher prevalence and risk of complications (acute rheumatic fever, post-streptococcal glomerulonephritis). Per IDSA guidelines, negative RADT in children should be confirmed with throat culture. In adults, negative RADT can be accepted without backup culture.
Patients with high Centor scores (4-5) but negative strep testing may have Fusobacterium necrophorum pharyngitis, particularly if ages 15-24. This organism causes Lemierre syndrome (thrombophlebitis of internal jugular vein with septic emboli) if untreated. While rare, consider F. necrophorum if severe pharyngitis with negative strep in adolescents/young adults, especially with unilateral symptoms or persistent fever despite symptomatic care.
Post-treatment testing (test of cure) is not recommended for uncomplicated strep pharyngitis. Many successfully treated patients remain strep carriers and will test positive despite clinical cure. Retesting is only indicated if symptoms persist or recur after completing the full antibiotic course, suggesting treatment failure or reinfection. Avoid the trap of retesting asymptomatic patients who feel better.
For low Centor scores where antibiotics are not indicated, provide effective symptom management: NSAIDs or acetaminophen for pain/fever, salt water gargles, throat lozenges, adequate hydration, and rest. Educate patients that viral pharyngitis typically resolves in 3-5 days regardless of treatment. Setting appropriate expectations reduces return visits and antibiotic-seeking behavior.
If a patient has high Centor score but also has trismus (difficulty opening mouth), muffled 'hot potato' voice, uvular deviation, or extreme difficulty swallowing, suspect peritonsillar abscess rather than simple pharyngitis. These patients need urgent ENT evaluation and possible incision and drainage, not just antibiotics. Do not send home without imaging or ENT consultation.
Your Modified Centor (McIsaac) Score estimates the probability that your sore throat is caused by Group A Streptococcus (GAS). A score of 0 or below corresponds to roughly a 1–2.5% probability of strep — testing and antibiotics are not recommended. A score of 1 carries about a 5–10% probability, where a Rapid Antigen Detection Test (RADT) may be considered but is often unnecessary. A score of 2 indicates approximately 11–17% probability, and RADT is recommended — treat only if positive. A score of 3 corresponds to about 28–35% probability, and testing is strongly recommended with treatment if positive. A score of 4–5 suggests a 51–53% probability, where empiric antibiotics or RADT confirmation may both be appropriate.
It is important to recognize that even at the highest scores, the probability of strep does not exceed about 50%. This means that clinical judgment and confirmatory testing remain essential. The score is a guide for resource-efficient decision-making, not a definitive diagnosis.
Use the Centor/McIsaac Score when evaluating a patient presenting with acute pharyngitis (sore throat) to determine whether streptococcal testing or empiric antibiotics are warranted. It is most valuable in primary care, urgent care, and emergency department settings where the goal is to reduce unnecessary antibiotic prescriptions while still treating true GAS pharyngitis to prevent complications like peritonsillar abscess and acute rheumatic fever.
The score is intended for patients aged 3 and older presenting with a sore throat as their primary complaint. It should be applied at the point of care after a focused history and physical examination. Guidelines from the IDSA, AHA, and ESCMID reference this score in their recommendations for pharyngitis management.
The Modified Centor Score was derived and validated primarily in outpatient adult populations, and its accuracy may vary in very young children or elderly patients with atypical presentations. It does not detect non-GAS causes of pharyngitis, including Group C/G Streptococcus, Fusobacterium necrophorum (Lemierre syndrome), or viral etiologies, which account for the majority of sore throat cases.
The score also does not account for local epidemiological factors such as strep prevalence in the community or recent outbreaks. Additionally, it should not be used in patients with signs of serious illness (respiratory distress, drooling, inability to swallow) that suggest peritonsillar abscess or epiglottitis, where urgent evaluation takes priority over scoring.
For related assessments, see CURB-65 Score, SIRS Criteria and qSOFA Score.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
Calculate the CURB-65 score to assess pneumonia severity and determine the need for hospitalization or ICU admission.
EmergencyEvaluate SIRS criteria for systemic inflammatory response. Two or more criteria (temperature, HR, RR, WBC) indicates SIRS. Note: Sepsis-3 definitions now prefer qSOFA and SOFA scoring.
EmergencyCalculate the qSOFA score for rapid bedside sepsis screening. Score ≥2 (altered mentation, RR ≥22, SBP ≤100 mmHg) identifies patients at high risk for poor outcomes — no labs required.